ASMB earnings: real EPS beat/miss history, analyst consensus Buy, P/E -44.90. Updated 2026-07-23.
Assembly Biosciences (ASMB) Research Hub
Assembly Biosciences (ASMB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 29.8 USD (-9.34%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -44.90, market cap 0.41B. This hub links to the full technical, earnings and options research available for ASMB.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 29.8 USD (-9.34%) |
| 52-week range | 23.07 USD – 37 USD |
| Trend regime | Range |
| 14-day RSI | 58 (Bullish) |
| Trailing P/E | -44.90 |
| Market cap | 0.41B |
| Dividend yield | 0.00% |
Available research for ASMB
Covered Call on ASMB: how it works, illustrative setup around the real 29.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ASMB: how it works, illustrative setup around the real 29.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ASMB: how it works, illustrative setup around the real 29.8 USD price, max profit/loss, breakeven and when to use it. Educational.
ASMB technical analysis: range, last 29.8 USD, RSI 58, 52w range 23.07 USD–37 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ASMB in?
Assembly Biosciences (ASMB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ASMB in an uptrend or downtrend?
As of 2026-09-11, ASMB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ASMB's trailing P/E ratio?
ASMB's trailing P/E is -44.90, with a market cap of 0.41B. See the earnings research page for full valuation detail.